It is worth mentioning that, given the obvious potential of serum albumin as a carrier system, there have been several clinically approved albumin-based formulations, such as for the treatment of cancer, hepatitis, and diabetes mellitus [5]. This evidence concerns the gene ALB and diabetes mellitus.